Esaote Group Unveils AI Technologies, Ultrasound System and PACS at ECR 2025

At ECR 2025, Esaote Group announced the company’s AI technology is now integrated into a variety of clinical applications: by optimizing workflows, reducing exam times and improving image quality, this technology empowers clinicians to make faster, data-driven decisions with heightened confidence.

In Ultrasound, Esaote's "Augmented Insight" AI technology now powers the entire system portfolio, from the flagship MyLabX90 to the newly launched MyLabC30. Together with the MyLabC25, Esaote's new Ultrasound C-series combines portability with excellent performance and Italian design, with a cleanable touch keyboard and a gesture-enabled trackpad for a smooth, efficient workflow. AI is instrumental in supporting advanced abdominal, prostate and breast applications, enabling radiologists to perform accurate, minimally invasive interventions with enhanced procedural confidence and outcomes.

In the field of MRI, Esaote launches a new AI platform called "e-SPADES.” This technology, developed in collaboration with the Amsterdam University Medical Center and with AIRS Medical, can reduce the overall examination time by up to 60% compared to conventional scanning, while delivering unparalleled image quality.

EBIT, the Esaote Group company that specializes in Healthcare Information Technology, showcased its latest innovative technology: SUITESTENSA ZefiRO, the new "cloud-native" PACS that draws on 25 years of experience in the Enterprise Imaging sector to deliver the most advanced "zero-footprint" (ZFP) technology.

The new PACS offers physicians and operators an easy, efficient and system-independent way to view medical images anywhere, improving diagnosis and treatment management. SUITESTENSA ZefiRO also features Suitestensa fAInd, an AI platform that provides rapid access to dozens of clinical applications to facilitate reporting and workflow.

"We are proud to present our latest technological innovations in the field of imaging to healthcare professionals. Our ongoing R&D efforts are focused on improving diagnostic accuracy and image-guided interventions by leveraging powerful technologies that increasingly rely on AI and advanced software applications as their backbone. Our new MRI and Ultrasound portfolio is supported by integrated IT platforms that enable healthcare professionals to focus on precision patient care," said Franco Fontana, CEO of Esaote S.p.A.